BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36630482)

  • 21. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
    Brichory FM; Misek DE; Yim AM; Krause MC; Giordano TJ; Beer DG; Hanash SM
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9824-9. PubMed ID: 11504947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.
    Pulido MA; DerHartunian MK; Qin Z; Chung EM; Kang DS; Woodham AW; Tsou JA; Klooster R; Akbari O; Wang L; Kast WM; Liu SV; Verschuuren JJGM; Aswad DW; Laird-Offringa IA
    J Neuroimmunol; 2016 Oct; 299():70-78. PubMed ID: 27725125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.
    Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
    Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
    Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.
    Kiers L; Altermatt HJ; Lennon VA
    Mayo Clin Proc; 1991 Dec; 66(12):1209-16. PubMed ID: 1660950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer.
    Feng S; Zhang X; Gu X; Zhou M; Chen Y; Wang C
    Comb Chem High Throughput Screen; 2023; 26(5):938-949. PubMed ID: 35490316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.
    Bazhin AV; Shifrina ON; Savchenko MS; Tikhomirova NK; Goncharskaia MA; Gorbunova VA; Senin II; Chuchalin AG; Philippov PP
    Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
    Ogino A; Choi J; Lin M; Wilkens MK; Calles A; Xu M; Adeni AE; Chambers ES; Capelletti M; Butaney M; Gray NS; Gokhale PC; Palakurthi S; Kirschmeier P; Oxnard GR; Sholl LM; Jänne PA
    Mol Oncol; 2021 Jan; 15(1):27-42. PubMed ID: 32191822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.
    Ocak S; Friedman DB; Chen H; Ausborn JA; Hassanein M; Detry B; Weynand B; Aboubakar F; Pilette C; Sibille Y; Massion PP
    J Thorac Oncol; 2014 Mar; 9(3):324-36. PubMed ID: 24518087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
    Lucchinetti CF; Kimmel DW; Lennon VA
    Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of distinct N-glycosylation patterns on extracellular vesicles from small-cell and non-small-cell lung cancer cells.
    Kondo K; Harada Y; Nakano M; Suzuki T; Fukushige T; Hanzawa K; Yagi H; Takagi K; Mizuno K; Miyamoto Y; Taniguchi N; Kato K; Kanekura T; Dohmae N; Machida K; Maruyama I; Inoue H
    J Biol Chem; 2022 Jun; 298(6):101950. PubMed ID: 35447118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer.
    Faber AC; Farago AF; Costa C; Dastur A; Gomez-Caraballo M; Robbins R; Wagner BL; Rideout WM; Jakubik CT; Ham J; Edelman EJ; Ebi H; Yeo AT; Hata AN; Song Y; Patel NU; March RJ; Tam AT; Milano RJ; Boisvert JL; Hicks MA; Elmiligy S; Malstrom SE; Rivera MN; Harada H; Windle BE; Ramaswamy S; Benes CH; Jacks T; Engelman JA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1288-96. PubMed ID: 25737542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H; Shiraishi H; Motomura M
    Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
    Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
    Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paraneoplastic retinopathy and optic neuropathy].
    Ikawa M; Kuriyama M
    Brain Nerve; 2010 Apr; 62(4):371-6. PubMed ID: 20420177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.
    Maddison P; Thorpe A; Silcocks P; Robertson JF; Chapman CJ
    Lung Cancer; 2010 Dec; 70(3):335-9. PubMed ID: 20371131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer.
    Silva M; Galeone C; Sverzellati N; Marchianò A; Calareso G; Sestini S; La Vecchia C; Sozzi G; Pelosi G; Pastorino U
    J Thorac Oncol; 2016 Feb; 11(2):187-93. PubMed ID: 26845115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Posttranslational Modification Autoantibodies Using Peptide Microarray.
    Li M; Wang H; Dai J; Xu M; Liu J; Ren J; Qin X; Kang X; Yu X
    Methods Mol Biol; 2021; 2344():99-106. PubMed ID: 34115354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.